Hafiz Mohmmadabdul

Hafiz Mohmmadabdul is an accomplished professional with extensive experience in drug discovery and development, particularly within neurodegenerative diseases. Currently serving as Program Lead in Bioinnovations at Emulate, Inc., Hafiz Mohmmadabdul has successfully initiated and led the development of a human vascularized micro-physiological blood-brain-barrier drug transport model. Previous roles include Program Lead at QurAlis, where strategies for RNA-therapeutics were implemented, and Lead Scientist at Applied BioMath, focusing on integrating disease biology and pharmacology for drug model development. Hafiz Mohmmadabdul also held key positions at Proteostasis Therapeutics, contributing to advancements in small molecule therapeutics for diseases like cystic fibrosis and Alzheimer's. An academic background in Protein Biochemistry from the University of Hyderabad complements this extensive industry expertise.